Analysis of TLR2 in Primary Endocrine Resistant of Breast Cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Toll-like receptor 2 (TLR2) is linked to tamoxifen resistance in triple-positive breast cancer. Downregulating TLR2 restored sensitivity, suggesting it may predict endocrine resistance.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Previous studies suggest Toll-like receptor 2 (TLR2) predicts endocrine resistance in HER2-positive breast cancer.
- The role of TLR2 in endocrine therapy resistance in triple-positive breast cancer (TPBC) remains unclear.
Purpose Of The Study
- To investigate the association between TLR2 and tamoxifen (TAM) resistance in TPBC.
- To explore TLR2 as a potential predictive marker for endocrine resistance.
Main Methods
- Bioinformatic analysis of TLR2 expression.
- Mass spectrometry, RT-PCR, and western blot on TPBC tissues and cell lines.
- Establishment and analysis of TAM-resistant cell lines (BT474-TAM) and TLR2 downregulation experiments.
Main Results
- TLR2 expression correlated with decreased relapse-free survival in breast cancer patients.
- TLR2 protein levels were significantly higher in TAM-resistant TPBC tissues and cell lines.
- Downregulation of TLR2 in BT474-TAM cells restored sensitivity to TAM.
Conclusions
- TLR2 is implicated in tamoxifen resistance in TPBC.
- TLR2 may serve as a predictive marker for primary endocrine resistance in TPBC.
- Targeting TLR2 could offer therapeutic potential for overcoming endocrine resistance.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...